Skip to main content
/
Aurobindo Pharma Limited (BOM:524804)
India flag India · Delayed Price · Currency is INR
1,170.60
+9.15 (0.79%)
At close: Jun 10, 2025

Aurobindo Pharma Revenue

In the fiscal year ending March 31, 2025, Aurobindo Pharma had annual revenue of 317.24B INR with 9.39% growth. Aurobindo Pharma had revenue of 83.82B in the quarter ending March 31, 2025, with 10.58% growth.

Revenue
317.24B
Revenue Growth
+9.39%
P/S Ratio
2.14
Revenue / Employee
12.19M
Employees
26,015
Market Cap
680.06B

Revenue Chart

Created with Highcharts 11.4.8Aurobindo Pharma Revenue - Annual247.7B​247.7B234.6B​234.6B248.6B​248.6B290.0B​290.0B317.2B​317.2B20212022202320242025-100B200B300B

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025317.24B27.22B9.39%
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,646.93B
HDFC Bank 2,728.47B
Tata Consultancy Services 2,553.24B
Bharti Airtel 1,729.85B
ICICI Bank 2,006.54B
State Bank of India 3,429.39B
Infosys 1,647.16B
Life Insurance Corporation of India 8,901.58B
Revenue Rankings

Aurobindo Pharma News

More News